Table 2.
EGD indication, procedure, and results
| EGD (n = 255) | |
|---|---|
| Time from admission (days, mean ± SD) | 8.3 ± 13 |
| EGD indication, n (%)* | |
| Anemia | 203 (79.6) |
| Melena | 49 (19.2) |
| Hemodynamic instability | 37 (14.5) |
| Hematemesis/blood in NGT | 35 (13.7) |
| Hematochezia | 35 (13.7) |
| Intubation solely for EGD, n (%) | 61 (23.9) |
| EGD results, n (%) | |
| Normal | 62 (24.3) |
| Ulcer | 59 (23.1) |
| EV | 20 (7.8) |
| Esophagitis | 48 (18.8) |
| Mallory–Weiss | 5 (2) |
| Gastritis | 32 (12.5) |
| NGT-induced lesion | 7 (2.7) |
| Other | 12 (4.7) |
| Multiple lesions | 41 (16.1) |
| Lesion considered responsible for GI bleeding | 110 (43.1) |
| Hemostatic procedure, n (%)** | 33 (12.9) |
| Hemostatic clip | 19 (58) |
| Epinephrine instillation | 16 (48) |
| EV ligature | 14 (42) |
| Other (Hemospray™/Gold probe™/APC) | 5 (15) |
EGD esophagogastroduodenoscopy, NGT nasogastric tube, EV esophageal varices, EBO endobrachyesophagus, GI gastrointestinal, APC Argon plasma coagulation. *Some patients had EGD for multiple indications. **Some patients received multiple means of hemostasis during EGD